Rustin G - Search Results

1

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

Ledermann J, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, Scott CL, Meier W, Shapira-Frommer R, Safra T, Matei D, Fielding A, Spencer S, Dougherty B, Orr M, Hodgson D, Barrett JC, Matulonis U. Ledermann J, et al. Among authors: rustin g. Lancet Oncol. 2014 Jul;15(8):852-61. doi: 10.1016/S1470-2045(14)70228-1. Epub 2014 May 31. Lancet Oncol. 2014. PMID: 24882434 Clinical Trial.

2

Weekly etoposide, methotrexate and actinomycin D, alternating with cyclophosphamide plus vincristine (EMA/CO): a phase II study in advanced gastric carcinoma.

Philip PA, Rustin GJ, Ledermann JA, Begent RH, Newlands ES, Bagshawe KD. Philip PA, et al. Among authors: rustin gj. Clin Oncol (R Coll Radiol). 1991 Jul;3(4):214-6. doi: 10.1016/s0936-6555(05)80742-3. Clin Oncol (R Coll Radiol). 1991. PMID: 1931762

3

EMOP/CA chemotherapy for the treatment of aggressive non-Hodgkin's lymphomas.

Smith DB, Ledermann JA, Boesen E, Newlands ES, Begent RH, Rustin GJ, Glaser MG, Bagshawe KD. Smith DB, et al. Among authors: rustin gj. Eur J Cancer Clin Oncol. 1989 Jun;25(6):991-4. doi: 10.1016/0277-5379(89)90160-0. Eur J Cancer Clin Oncol. 1989. PMID: 2753060

4

The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours.

Ledermann JA, Holden L, Newlands ES, Begent RH, Rustin GJ, Bagshawe KD, Brampton M. Ledermann JA, et al. Among authors: rustin gj. Br J Urol. 1994 Aug;74(2):225-30. doi: 10.1111/j.1464-410x.1994.tb16591.x. Br J Urol. 1994. PMID: 7522874

5

Patient compliance with prolonged oral altretamine treatment in relapsed ovarian cancer.

Lee CR, Nicholson PW, Ledermann JA, Rustin GJ. Lee CR, et al. Among authors: rustin gj. Eur J Gynaecol Oncol. 1996;17(2):99-103. Eur J Gynaecol Oncol. 1996. PMID: 8654477 Clinical Trial.

6

Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125.

Rustin GJ, Nelstrop AE, Crawford M, Ledermann J, Lambert HE, Coleman R, Johnson J, Evans H, Brown S, Oster W. Rustin GJ, et al. J Clin Oncol. 1997 Jan;15(1):172-6. doi: 10.1200/JCO.1997.15.1.172. J Clin Oncol. 1997. PMID: 8996139 Clinical Trial.

7

Surveillance policy for stage I ovarian germ cell tumors.

Dark GG, Bower M, Newlands ES, Paradinas F, Rustin GJ. Dark GG, et al. Among authors: rustin gj. J Clin Oncol. 1997 Feb;15(2):620-4. doi: 10.1200/JCO.1997.15.2.620. J Clin Oncol. 1997. PMID: 9053485

8

A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma. A North Thames Ovary Group Study.

Lambert HE, Rustin GJ, Gregory WM, Nelstrop AE. Lambert HE, et al. Among authors: rustin gj. Ann Oncol. 1997 Apr;8(4):327-33. doi: 10.1023/a:1008256431090. Ann Oncol. 1997. PMID: 9209661 Free article. Clinical Trial.

9

Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel.

Bridgewater JA, Nelstrop AE, Rustin GJ, Gore ME, McGuire WP, Hoskins WJ. Bridgewater JA, et al. Among authors: rustin gj. J Clin Oncol. 1999 Feb;17(2):501-8. doi: 10.1200/JCO.1999.17.2.501. J Clin Oncol. 1999. PMID: 10080591

10

Use of tumour markers in monitoring the course of ovarian cancer.

Rustin GJ, Nelstrop AE, Bentzen SM, Piccart MJ, Bertelsen K. Rustin GJ, et al. Ann Oncol. 1999;10 Suppl 1:21-7. doi: 10.1023/a:1008351216605. Ann Oncol. 1999. PMID: 10219449

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

309 results

Search Page